Skip to content

The effect of two different doses of the drug on hemodynamic responses in patients undergoing laparoscopic cholecystectomy

Comparison study of two doses of magnesium sulfate on hemodynamic response to endotracheal intubation in laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191229045935N1
Enrollment
60
Registered
2020-03-04
Start date
2019-02-27
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing CABG.

Interventions

Intervention 1: Intervention group: Magnesium sulfate 30mg / kg infusion within 5 minutes which continues before induction. The studied drugs were manufactured by Judge Tabriz Company from Alborz Broa

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ASA II-III Patients Candidate for Laparoscopic Elective Cholecystectomy

Exclusion criteria

Exclusion criteria: Emergency Surgery Probability of intubation problem Sensitivity to magnesium sulfate Cardiac arrhythmia Serum creatinine above 2 mg / dl pregnant women Patients with severe heart valve disorders Patients with aortic stenosis

Design outcomes

Primary

MeasureTime frame
Heart rate. Timepoint: At the time of tracheal, and 2, 4, 6, and 10 minutes after tracheal intubation. Method of measurement: Digital barometer.;Systolic blood pressure, diastolic blood pressure, and mean blood pressure. Timepoint: systolic blood pressure, diastolic blood pressure, and mean blood pressure before infusion to induction were recorded at different time points, including anesthesia induction, at the time of tracheal, and 2, 4, 6, and 10 minutes after tracheal intubation. Method of measurement: Mercury barometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJafar Kazemeini

Kashan University of Medical Sciences

kazemeini-j@mail.kaums.ac.ir+98 31 5550 0111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026